Avanos Medical

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Avanos Medical and other ETFs, options, and stocks.

About AVNS

Avanos Medical, Inc. is a medical technology company, which engages in delivering clinically superior medical device solutions and products to healthcare providers and patients. The company was founded on February 25, 2014 and is headquartered in Alpharetta, GA. 

CEO
David C. Pacitti
CEODavid C. Pacitti
Employees
2,227
Employees2,227
Headquarters
Alpharetta, Georgia
HeadquartersAlpharetta, Georgia
Founded
2014
Founded2014
Employees
2,227
Employees2,227

AVNS Key Statistics

Market cap
522.21M
Market cap522.21M
Price-Earnings ratio
-1.10
Price-Earnings ratio-1.10
Dividend yield
Dividend yield
Average volume
561.39K
Average volume561.39K
High today
$11.46
High today$11.46
Low today
$11.06
Low today$11.06
Open price
$11.06
Open price$11.06
Volume
615.79K
Volume615.79K
52 Week high
$21.12
52 Week high$21.12
52 Week low
$9.30
52 Week low$9.30

Stock Snapshot

The current Avanos Medical(AVNS) stock price is $11.23, with a market capitalization of 522.21M. The stock trades at a price-to-earnings (P/E) ratio of -1.10.

During the trading session on 2025-11-08, Avanos Medical(AVNS) shares reached a daily high of $11.46 and a low of $11.06. At a current price of $11.23, the stock is +1.6% higher than the low and still -2.0% under the high.

Trading activity shows a volume of 615.79K, compared to an average daily volume of 561.39K.

Over the past 52 weeks, Avanos Medical(AVNS) stock has traded between a high of $21.12 and a low of $9.30.

Over the past 52 weeks, Avanos Medical(AVNS) stock has traded between a high of $21.12 and a low of $9.30.

AVNS News

TipRanks 2d
Avanos Medical Reports Mixed Q3 2025 Results

Avanos Medical, Inc. ( (AVNS) ) has released its Q3 earnings. Here is a breakdown of the information Avanos Medical, Inc. presented to its investors. Elevate Y...

Simply Wall St 2d
Avanos Medical: Extended Losses Undercut Turnaround Hopes Despite Discounted Valuation

Avanos Medical (AVNS) remains unprofitable, with losses widening at an average rate of 74.4% per year over the past five years. Improving profit growth has prov...

Avanos Medical: Extended Losses Undercut Turnaround Hopes Despite Discounted Valuation
TipRanks 3d
Avanos Medical’s Earnings Call: Growth Amid Challenges

Avanos Medical, Inc. ((AVNS)) has held its Q3 earnings call. Read on for the main highlights of the call. Meet Your ETF AI Analyst Discover how TipRanks' ETF AI...

More AVNS News

TipRanks 3d
Avanos reports Q3 adjusted EPS 22c, consensus 12c

Reports Q3 revenue $177.8M, consensus $164.5M. “I am pleased with our third quarter results, both operationally and commercially,” said David Pacitti, Avanos (A...

Nasdaq 3d
Avanos Medical Q3 Earnings and Revenues Beat Estimates

Avanos Medical (AVNS) came out with quarterly earnings of $0.22 per share, beating the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of...

Avanos Medical Q3 Earnings and Revenues Beat Estimates

People also own

Based on the portfolios of people who own AVNS. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.